Senseonics Halts Sales of Eversense Implantable CGM in Wake of COVID-19 Crisis

Senseonics, makers of the first-ever implantable continuous glucose monitor Eversense, will no longer sell CGMs to new customers but for now will remain available to current users.

Source: Diabetes Mine - April 1, 2020 Category: Endocrinology Authors: Mike Hoskins and Amy Tenderich Source Type: blogs